Leucocyte-rich and platelet-rich fibrin for the treatment of bisphosphonate-related osteonecrosis of the jaw: a prospective feasibility study.

@article{Kim2014LeucocyterichAP,
  title={Leucocyte-rich and platelet-rich fibrin for the treatment of bisphosphonate-related osteonecrosis of the jaw: a prospective feasibility study.},
  author={Jin-Woo Kim and Sun-Jong Kim and M Kim},
  journal={The British journal of oral & maxillofacial surgery},
  year={2014},
  volume={52 9},
  pages={854-9}
}
Our aim was to assess the feasibility of using leucocyte-rich and platelet-rich fibrin (L-PRF) for the treatment of bisphosphonate-related osteonecrosis of the jaw (BRONJ) in a single group study. After treatment with L-PRF, the response of each patient was recorded 1 month and 4 months postoperatively. Further assessments were made of the site, stage, concentration of c-terminal crosslinked telopepide of type 1 collagen, and actinomycosis. Among the total of 34 patients, 26 (77%) showed… CONTINUE READING

Connections & Topics

Mentioned Connections BETA
Our aim was to assess the feasibility of using leucocyte - rich and platelet - rich fibrin ( L - PRF ) for the treatment of bisphosphonate - related osteonecrosis of the jaw ( BRONJ ) in a single group study .
Leucocyte - rich and platelet - rich fibrin for the treatment of bisphosphonate - related osteonecrosis of the jaw : a prospective feasibility study .
Our aim was to assess the feasibility of using leucocyte - rich and platelet - rich fibrin ( L - PRF ) for the treatment of bisphosphonate - related osteonecrosis of the jaw ( BRONJ ) in a single group study .
Leucocyte - rich and platelet - rich fibrin for the treatment of bisphosphonate - related osteonecrosis of the jaw : a prospective feasibility study .
All Topics